Insider Trading February 27, 2026

Hippo Holdings Executive Sells 600 Shares Ahead of Earnings; Stock Trades Below Sale Price

Torben Ostergaard disposed of roughly $18,266 in Hippo stock under a 10b5-1 plan as the insurer reports stronger Q4 trends

By Ajmal Hussain HIPO
Hippo Holdings Executive Sells 600 Shares Ahead of Earnings; Stock Trades Below Sale Price
HIPO

Torben Ostergaard, CEO of Spinnaker at Hippo Holdings Inc (NYSE: HIPO), sold 600 shares on February 25, 2026 under a Rule 10b5-1 trading plan, generating about $18,266 in proceeds. The shares were sold between $30.19 and $30.56 while the stock currently trades at $28.76. Hippo recently reported robust fourth-quarter 2025 results, including growth in gross written premium and a shift toward a more diversified insurance portfolio. Following the sale, Ostergaard directly holds 46,094 shares, including 42,427 RSUs. The transaction occurred one week before Hippo's March 6, 2026 earnings release.

Key Points

  • Torben Ostergaard sold 600 Hippo Holdings shares on February 25, 2026 for about $18,266, at prices between $30.19 and $30.56.
  • The sale was executed under a Rule 10b5-1 trading plan dated August 22, 2025; post-transaction, Ostergaard directly owns 46,094 shares, including 42,427 RSUs.
  • Hippo reported strong fourth-quarter 2025 results, showing an increase in gross written premium and a strategic move to diversify its insurance portfolio, ahead of a March 6, 2026 earnings report.

Torben Ostergaard, who serves as CEO of Spinnaker at Hippo Holdings Inc (NYSE: HIPO), sold 600 shares of the insurer's common stock on February 25, 2026, yielding approximately $18,266 in proceeds.

The sales were executed at prices ranging from $30.19 to $30.56 per share. As of the reporting in the filing, Hippo's stock is trading at $28.76, which is below the prices at which Ostergaard sold. An InvestingPro valuation cited a Fair Value of $34.97 for the company, suggesting a divergence between the market price and the assessed intrinsic value.

According to a Form 4 filed with the Securities and Exchange Commission, the sales were made pursuant to a Rule 10b5-1 trading plan dated August 22, 2025. The filing shows that after the disposition, Ostergaard directly owns 46,094 shares of Hippo Holdings Inc. That total includes 42,427 Restricted Stock Units, or RSUs.

The timing of the sale is notable because it took place seven days prior to Hippo's scheduled earnings report on March 6, 2026. At the time of the report, the company's shares were carrying a price-to-earnings ratio of 12.36.


Separately, Hippo published financial results for the fourth quarter of 2025 that the company described as strong. The quarterly report highlighted a meaningful uptick in gross written premium, which indicates top-line growth in the firm's insurance operations. Management also has been pursuing a strategic shift toward diversifying the company's insurance portfolio, a move the company believes will support future performance.

These operational developments - higher gross written premium and a broader portfolio composition - have been framed in the earnings report as signs of improving operational health. The report noted these trends may be supporting renewed investor confidence and overall positive momentum in the business.

Investors and market observers will be watching Hippo's upcoming earnings release closely, given the insider sale and the recent financial disclosures. The Form 4 filing and the company's own quarterly statements together provide the current factual record on ownership, recent insider activity, and reported operational progress.

Risks

  • Price volatility risk: The company's shares were trading at $28.76, below the prices at which the insider sold, indicating near-term market price movement that could affect investor returns - this impacts equity markets and financial sector participants.
  • Timing uncertainty: The insider sale occurred seven days before the March 6, 2026 earnings release, a timing that may raise questions for market participants assessing short-term informational effects - this affects market perception in the insurance and broader financial sectors.
  • Operational execution risk: While the company reported increased gross written premium and diversification of its insurance portfolio, future performance depends on execution of those initiatives and may influence insurer valuations and investor confidence.

More from Insider Trading

Real Alloys CFO Sells $256,547 in Stock as Company Advances Merger and Supply Partnerships Feb 27, 2026 Figma CTO Disposes $1.54M in Shares Amid Volatile Stock Moves Feb 27, 2026 Crown Castle General Counsel Sells $401,481 in Shares; Receives RSUs That Vest Over Three Years Feb 27, 2026 NAII CEO Makes Small Share Purchase as Company Secures Waiver on Credit Covenants Feb 27, 2026 Neuronetics Executive Sells $4,626 in Stock to Cover RSU Tax Bill as Company Posts Strong Revenue Gains Feb 27, 2026